ELDERPHARM

Elder Pharmaceuticals Limited has informed the Exchange regarding the Outcome of Board Meeting of the Company held on February 03, 2016.

Elder Pharmaceuticals Limited has informed the Exchange that the Meeting of the Board held on September 28, 2015 regarding the sale of the step down overseas subsidiaries, the matter was discussed by the Board of the Company and it was deliberated that complying with the legal parameters, the proposal should be put forward before the Board of Elder Pharmaceuticals Ltd. by the Board of Elder International , FZCO - Dubai for further consideration and necessary approval.

Elder Pharmaceuticals Limited has informed the Exchange that the Board at its meeting held on July 15, 2015, has passed resolution for appointment of Dr. (Mrs.) Babita Bhatia as Additional Director (Woman Director) w.e.f . July 15, 2015 in compliance with the Companies Act , 2013 and the amendments made to Clause 49 of the Listing Agreement .

Elder Pharmaceuticals Limited has informed the Exchange that Board Considered and approved the Financial year of the Company w.e.f. July 01, 2014 to June 30, 2015.

Elder Pharmaceuticals Limited has submitted to the Exchange outcome of Board Meeting held on August 21, 2014. 1) The Board appointed Dr. Anuj Saxena as Chief Operating Officer (COO) of the Company without Remuneration for a period from August 21, 2014 to August 20, 2019.

Elder Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 04, 2014.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 15, 2014 has approved the following : (1). Resignation of Mr. James McEuen as Director of the Company.(2). Appointment of Mr. Vijendra Jain as Company Secretary & Compliance Officer of the Company in place of Mr. S.P. Date who has retired.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on October 11, 2013, has decided to appoint Mr. Alok Saxena as the Managing Director and Chief Executive Officer of the Company with effect from October 11, 2013, for a period of five years, subject to the approval of the shareholders.

Elder Pharmaceuticals Limited has informed the Exchange that at a meeting of the Board of Directors of the Company held on July 11, 2013, the Board with a view to reducing the debt of the Company has approved the proposal for carrying out restructuring of Company's business involving either raising of capital, hiving off of assets or other strategic options and have decided to appoint advisors for this purpose.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its Meeting held on May 14, 2013 has decided not to proceed with amalgamation of Elder Health Care Ltd., with the Company.

Elder Pharmaceuticals Limited has informed the Exchange regarding the outcome of Board Meeting held on August 02, 2012.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 10, 2011 amongst others, the following decisions were taken: (1) To form a 50:50 Joint Venture in Guernsey for web marketing of VMS products manufactured by UK and European companies. (2) To approve the appointment of Mr. Madhav Joshi as President -Pharma of the Company.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on December 23, 2010, has approved the allotment of fully paid 1188 of units of Rs. 10,00,000/- each under Secured Redeemable Non Convertible Debenture issue.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company met today i.e. March 27, 2008 for discussing 1) alignment of business in two broad heads, namely Pharmaceuticals and Consumer Products Division and 2) merger of Elder Projects Limited with the Company. In view of the implications and impact of certain recent budget notifications on Central excise duty on pharmaceutical products, as interpreted and clarified now, which would not currently render any strategic advantage to the Company, it has been decided by the Board not to go ahead with the propo

Elder Pharmaceuticals Limited has informed the Exchange that at the meeting of the Board of Directors of the Company held on March 28, 2006 amongst others the following decisions were taken:(1) To purchase, subject to requisite permissions, consents, approvals, etc. if any, an undertaking for manufacture of injectables in liquid oral dosage form of Elder Projects Limited located at Patalganga,District Raigad;(2) To grant Employee Stock Options to the extent of 4,00,000 shares under the Elder ESOP 2004. The Managing Director has been authorized by the board to finalise the documentation in res